SCHEMBL623928

SCHEMBL623928

COc1ccc(-c2cn3nc(NC4CCN(S(C)(=O)=O)CC4)sc3n2)cc1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FYN P06241 1/20 0.49
F2RL3 Q96RI0 2/20 0.42
SSTR5 P35346 2/20 0.42
CDK1 P06493 7/20 0.41
CDK4 P11802 7/20 0.41
CCND1 P24385 7/20 0.41
CDK2 P24941 7/20 0.41
MAPT P10636 2/20 0.41
BRD4 O60885 1/20 0.41
BRD9 Q9H8M2 1/20 0.41
DYRK1A Q13627 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
IKBKB O14920 1/20 0.39
THRB P10828 1/20 0.39
CASK O14936 1/20 0.39
ROCK2 O75116 1/20 0.39
CDKL5 O76039 1/20 0.39
STK10 O94804 1/20 0.39
CDK14 O94921 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1946301 0.86 FYN (0.54) FYNF2RL3SSTR5MAPTNPC1
SCHEMBL1945924 0.85 FYN (0.66) FYNF2RL3SSTR5MAPTNPC1
SCHEMBL2255826 0.84 FYN (0.52) FYNF2RL3SSTR5MAPTNPC1
SCHEMBL624431 0.83 FYN (0.48) FYNF2RL3CDK1CDK4CCND1
SCHEMBL623927 0.81 FYN (0.72) FYN
SCHEMBL626172 0.80 DYRK1A (0.38) FYNCDK1CDK4CCND1CDK2
SCHEMBL626187 0.77 JAK3 (0.38) FYNF2RL3CDK1CDK4CCND1
SCHEMBL626165 0.77 IDO1 (0.47) F2RL3CDK1CDK4CCND1CDK2
SCHEMBL1946744 0.77 FYN (0.56) FYNF2RL3MAPTNPC1RAB9A
SCHEMBL627168 0.76 CCNE1 (0.39) CDK1CDK4CCND1CDK2IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020217-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 WO disclosed